XML 68 R49.htm IDEA: XBRL DOCUMENT v3.23.1
Share Capital (Tables)
 12 Months Ended
Dec. 31, 2022
Disclosure Of Classes Of Share Capital Text Block Abstract  
Schedule of residual value to common shares
Gross proceeds  $3,986,100 
Less: total fair value of warrant liability   (2,288,327)
Residual value to common shares  $1,697,773 

 
Schedule residual value to be allocated to common shares and to the warrants
   Number of stock options  

Weighted Average

Exercise Price

 
Outstanding options, December 31, 2020   328,068   $13.99 
Granted   100,500   $11.50 
Expired/Cancelled   (14,000)  $16.38 
Outstanding options, December 31, 2021   414,568   $13.88 
Granted   1,145,000   $1.15 
Expired/Cancelled   (53,430)  $30.90 
Outstanding options, December 31, 2022   1,506,138   $3.53 

 

   Number of
RSU’s		   Weighted Average
Issue Price		 
Outstanding RSU, December 31, 2021 
-
   $
-
 
Granted   3,195,000   $1.05 
Exercised   (30,000)  $1.10 
Outstanding RSU, December 31, 2022   3,165,000   $1.05 

 

   Number of
options		   Weighted average exercise price 
Outstanding agent options, December 31, 2020   452,523   $8.02 
Expired   (6,597)  $52.68 
Outstanding agent options, December 31, 2021   445,926   $7.51 
Granted   487,283   $2.51 
Expired   (1,702)  $20.49 
Outstanding agent options, December 31, 2022   931,507   $4.12 

 

   Number of
Warrants		   Weighted average exercise price 
Outstanding, December 31, 2020   3,591,533   $10.55 
Granted   2,142,857   $4.00 
Exercised   (544,415)  $5.54 
Expired   (68,647)  $62.87 
Outstanding, December 31, 2021   5,121,328   $7.64 
Granted   27,399,999   $0.93 
Expired   (128,386)  $33.47 
Outstanding, December 31, 2022   32,392,941   $1.76 

 
Schedule residual value to be allocated to common shares and to the warrants
Grant Date  Number of
options outstanding		   Number of
options exercisable		   Weighted Average Exercise Price   Expiry date  Remaining contractual
life (years)		 
24-Dec-18   12,896    12,896    54.00   24-Dec-23   0.98 
15-Jan-19   828    828    54.00   15-Jan-24   1.04 
21-Mar-19   12,345    12,345    59.00   21-Mar-24   1.22 
01-Jan-20   2,069    2,069    54.00   01-Jan-24   1.00 
15-Nov-20   95,000    95,000    6.00   15-Nov-30   7.88 
15-Nov-20   161,500    161,500    6.00   15-Nov-25   2.88 
02-Jan-21   57,000    49,875    11.50   02-Jan-26   3.01 
02-Jan-21   5,000    4,375    11.50   02-Jan-31   8.01 
18-Jan-21   14,500    12,688    11.50   18-Jan-26   3.05 
01-Jan-22   20,000    10,000    4.00   29-Oct-26   3.83 
13-Apr-22   795,000    198,750    1.10   13-Apr-27   4.28 
12-Jul-22   330,000    55,000    1.10   12-Jul-25   2.53 
Total   1,506,138    615,326    3.53       3.86 

 

Grant Date  Number of RSU’s outstanding   Number of RSU’s exercisable   Weighted Average Issue Price 
09-Mar-22   2,250,000    1,050,000   $1.03 
13-Apr-22   825,000    416,250   $1.10 
12-Jul-22   90,000    22,500   $1.10 
Outstanding RSU, December 31, 2022   3,165,000    1,488,750   $1.05 

 

Grant Date  Number of
options
outstanding		   Number of
options
exercisable		   Weighted
Average
Exercise Price		   Expiry date  Remaining contractual life (years) 
                    
29-Sep-20   113,500    113,500   $6.60   28-Sep-25   3.00 
29-Sep-20   266,000    266,000   $6.85   28-Sep-25   3.00 
31-Dec-20   64,724    64,724   $11.50   30-Jun-24   1.00 
11-Jan-22   434,783    434,783   $2.53   11-Jan-27   4.00 
01-Apr-22   52,500    52,500   $2.30   08-Mar-27   4.00 
Total   931,507    931,507   $3.38       3.45 

 

Grant Date  Number of
Warrants
outstanding
and exercisable		   Exercise Price   Expiry date 
29-Sep-20   1,805,585   $6.85    28-Sep-25 
31-Dec-20   1,294,500   $11.50    30-Jun-24 
03-Nov-21   1,892,857   $2.30    03-Nov-26 
11-Jan-22   9,999,999   $2.30    11-Jan-27 
12-Oct-22   17,400,000   $0.14    12-Oct-27 
Total   32,392,941   $1.76      

 

●On January 11, 2022 as part of an underwritten public offering, the Company issued a total of 9,999,999 share purchase warrants, exerciseable at $2.30 per warrant and with a term of five years.

 

●On October 12, 2022 as part of the underwritten public offering, the Company issued at total of 17,400,000 share purchase warrants, exerciseable at $0.14 per warrant and with at term of five years.

 
Schedule of weighted average assumptions
   2022   2021   2020 
Exercise price  $1.10   $11.50   $6.47 
Risk-free interest rate   2.56-3.01%   0.23%   1.68%
Expected life   5    5    5 
Annualized volatility   75-80%   85%   83%
Dividend rate   0.00%   0.00%   0.00%